Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

X4 Pharmaceuticals (XFOR) Tax Rate (2020 - 2025)

Historic Tax Rate for X4 Pharmaceuticals (XFOR) over the last 6 years, with Q3 2025 value amounting to 0.1%.

  • X4 Pharmaceuticals' Tax Rate rose 1400.0% to 0.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.32%, marking a year-over-year increase of 1900.0%. This contributed to the annual value of 0.83% for FY2024, which is 7600.0% down from last year.
  • As of Q3 2025, X4 Pharmaceuticals' Tax Rate stood at 0.1%, which was up 1400.0% from 0.14% recorded in Q2 2025.
  • X4 Pharmaceuticals' 5-year Tax Rate high stood at 10.76% for Q1 2025, and its period low was 1.14% during Q3 2023.
  • Over the past 5 years, X4 Pharmaceuticals' median Tax Rate value was 0.03% (recorded in 2021), while the average stood at 0.44%.
  • As far as peak fluctuations go, X4 Pharmaceuticals' Tax Rate tumbled by -12000bps in 2023, and later skyrocketed by 108000bps in 2025.
  • X4 Pharmaceuticals' Tax Rate (Quarter) stood at 0.01% in 2021, then plummeted by -385bps to 0.05% in 2022, then tumbled by -259bps to 0.17% in 2023, then tumbled by -277bps to 0.65% in 2024, then skyrocketed by 115bps to 0.1% in 2025.
  • Its Tax Rate was 0.1% in Q3 2025, compared to 0.14% in Q2 2025 and 10.76% in Q1 2025.